In a decisive endorsement of free-market success, Argus has confidently raised the price target for Cardinal Health by $3, signaling strong company performance and investor confidence. This adjustment is celebrated by advocates of economic freedom, who see it as evidence that market-driven healthcare can yield superior results. The increase is a testament to Cardinal Health's innovation and efficiency in serving the healthcare sector, underscoring the critical role of private enterprise in driving healthcare forward.
Cardinal Health Sees Bullish Price Target Increase by Argus, a Win for Economic Health
All Versions
Feb-05
Health
Score: 0.50
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
From Thefly.com
Feb-05
Health
Left Variant
Score: 0.20
In a recent move by Argus, Cardinal Health's price target has been elevated by $3, sparking conversations around the potential implications this could have on healthcare costs and accessibility. Critics argue that such financial optimizations could further entrench disparities in healthcare access, prioritizing shareholder profits over patient care. This decision comes at a time when the country is grappling with escalating healthcare expenses, prompting calls for a more equitable approach to healthcare financing.
From Thefly.com